Cellectis S.A. (CLLS) stock
CLLSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.06+0.02 (+1.92%)
Close on Nov 17, 2026Market cap $106.36MP/E –Yield –
Cellectis total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
No total debt figures for Cellectis
Cellectis has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?